APA (7th ed.) Citation

Cantilena, S., Gasparoli, L., Pal, D., Heidenreich, O., Klusmann, J., Martens, J. H. A., . . . de Boer, J. (2022). Direct targeted therapy for MLL‐fusion‐driven high‐risk acute leukaemias. Clinical & Translational Medicine, 12(6), 1. https://doi.org/10.1002/ctm2.933

Chicago Style (17th ed.) Citation

Cantilena, Sandra, et al. "Direct Targeted Therapy for MLL‐fusion‐driven High‐risk Acute Leukaemias." Clinical & Translational Medicine 12, no. 6 (2022): 1. https://doi.org/10.1002/ctm2.933.

MLA (9th ed.) Citation

Cantilena, Sandra, et al. "Direct Targeted Therapy for MLL‐fusion‐driven High‐risk Acute Leukaemias." Clinical & Translational Medicine, vol. 12, no. 6, 2022, p. 1, https://doi.org/10.1002/ctm2.933.